Health Management & Information Science

Health Management & Information Science

Schema.org Annotations in Health and Life Sciences: A Methodological Scoping Review of Validation Practices, Semantic Interoperability Gaps, and Clinical Applicability

Document Type : Review

Author
Ph.D. Knowledge and Information Science, Shahid Chamran University, Ahvaz, Iran
10.30476/jhmi.2026.111852.1373
Abstract
Background:Schema.org annotations have been increasingly adopted in health information systems to enhance the discoverability and semantic interoperability of data in Health and Life Sciences.However,the validation practices,semantic integration levels,and clinicalapplicability of these annotations remain poorly understood.
Objective:This scoping review aims to systematically map validation methods,semantic interoperability gaps,methodological weakness patterns,and evolutionary trends in the application of Schema.org annotations in the medical and health domain.
Methods:A scoping review was conducted following ArkseyandO'Malley's five step framework and reported in accordance with the PRISMA extension for Scoping Reviews(PRISMA-ScR).A comprehensive search was conducted in Emerald,Science Direct,IEEE Xplore,WebofScience,Scopus,and PubMed from inception to December2025,and an update search was performed in January2026 to cover any potential articles published in this emerging field.The searches were carried out without any temporal or linguistic restrictions.Studies focusing on Schema.org in medicine,health,and related domains were included.Data were extracted on validationmethods,integration with clinical standards,reported limitations,and evaluative approaches.
Results:Thirty‑three articles were included.Of these,19of33articles(58%)had some form of empirical or demonstrative evaluation,while14of33articles(42%)lacked any documented validation method.Semanticvalidation was the most frequent(9of19articles with evaluation,47%),but only6of33articles(18%)combined twoorthree validation levels (technical,semantic,practical).Major gaps included:(1)lack of a domain‑specific goldstandard for semanticevaluation(8articles),(2)non‑reproducibility due to proprietary infrastructures(9articles),and(3)complete neglect of clinicalvalidity(0articles evaluated real clinical outcomes).Goal‑implementation alignment was observed in26of33articles(79%),almost exclusively among those using Bioschemas profiles or direct linkage to clinical codingsystems.Recurring methodological weaknesses were failure to report limitations(12of33articles,36%)and lackof empiricalevaluation(12of33articles,36%).
Conclusions:Schema.org shows considerable potential for improving data discoverability and interoperability,but remains methodologically immature for health informationsystems.While technical and semanticvalidations are progressing,clinicalvalidation is entirely absent.A minimum reporting checklist,domain‑specific gold standards,and field trials in real clinical settings areurgently needed.
Keywords
Subjects


Articles in Press, Accepted Manuscript
Available Online from 21 November 2026